NCT04847544Phase 2Completed

A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.

Study sponsor: Aldeyra Therapeutics, Inc. · ALDX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2021-10-15Actual
Enrollment · participants11Actual
Source updated2025-02-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview